Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Author:
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Elsevier BV
Subject
Hepatology
Reference49 articles.
1. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann Intern Med,2006
2. Natural history of hepatitis C;Thomas;Clin Liver Dis,2005
3. Anti-fibrogenic strategies and the regression of fibrosis;Kisseleva;Best Pract Res Clin Gastroenterol,2011
4. Statins and cancer prevention;Demierre;Nat Rev Cancer,2005
5. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database;Welzel;Hepatology,2011
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05
2. Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma;Nano Research;2023-08-08
3. Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms;Biochemical Pharmacology;2023-08
4. Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers;Thoracic Cancer;2023-07-03
5. Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications;Cells;2023-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3